Australian Pharmaceutical Industries drops its stake in Sigma Healthcare.
Australan Pharmaceutical Industries has just confirmed the sale of its shares in Sigma Healthcare Limited, acquired last year as part of the now aborted proposed merger between the companies.
The sale of 137,264,592 Sigma shares means API now no holds no shares in Sigma. API Chairman Mark Smith said “the strategic and commercial fundamentals that made the merger a compelling proposigion for both sets of shareholders have significantly diminished”.
He said selling the Sigma shares would allow API to futher accelerate its focus on its existing portfolio.
More details in tomorrow’s issue of Pharmacy Daily.
This Pharmacy Daily breaking news is brought to you by JPH Group